Orexo, J&J deal

Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. and Janssen Pharmaceutica N.V. subsidiaries received worldwide, exclusive rights to develop and commercialize OX-CLI and OX-ESI. The comp...